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Depleted uranium (DU) is a by-product of the
enrichment process of natural uranium (Priest
2001). The release of uranium into the environ-
ment presents a threat to human and ecologic
health in many parts of world (Hass et al. 1998;
Murray et al. 2002). DU shares chemical prop-
erties with natural or enriched uranium, but the
major hazard rendered by DU results from its
heavy metal toxicity rather than from radiologic
toxicity (Fisenne and Welford 1986; Priest
2001). The adverse health effects of DU com-
pounds are partially dependent on its chemical
form. Uranium compounds in +2 to +4 valence
states are essentially insoluble. However, in vivo
soluble uranium is always hexavalent, regardless
of the oxidation state of uranium compound
taken up (Edison 1994). It is this form (+6) that
is of toxicologic importance. Because of their
high affinity for phosphate, carboxyl, and
hydroxyl groups, uranyl compounds readily
combine with proteins and nucleotides to form
stable complexes (Moss 1985).
Serum uranium forms a variety of nondif-
fusible complexes such as uranium–albumin
compounds and diffusible ones such as ionic
uranyl hydrogen carbonate complex (Moss
1985). Although the most characteristic
response to DU exposure either short or long
term is renal dysfunction (Domingo 1995;
Leggett 1989; Zamora et al. 1998), uranium is
also localized within the central nervous system,
testes, lymph nodes, and spleen, suggesting the
potential for uranium to cause health problems
at these sites (Domingo 2001; Pellmar et al.
1999; Wrenn et al. 1985). Uranium-induced
pathological changes in the testes and thyroid
glands have been documented (Malenchenko
et al. 1978).
In vitro studies have examined the effects
of DU on a variety of cell types. For example,
Chinese hamster ovary cells exposed to DU
exhibit lower cell viability, depressed cell cycle
kinetics, and increased sister chromatid
exchanges, micronuclei, and chromosomal
aberrations after DU exposure (Lin et al.
1993). Kidney cells release lactate dehydroge-
nase upon uranium exposure (Furuya et al.
1997), whereas human osteoblast cells are
transformed to a neoplastic phenotype after
in vitro DU exposure (Miller et al. 1998).
More important to this investigation, some
studies indicated that immune cells are also
involved in DU toxicity. Macrophages can
actively internalize the uranium, with the subse-
quent occurrence of cell apoptosis (Kalinich and
McClain 2001; Kalinich et al. 2002). Other evi-
dence suggests the involvement of cytokine gene
expression in DU toxicity, and the changes of
some of these genes are associated with immune
responses. For example, recent studies demon-
strated that DU induces abnormal expression
and release of tumor necrosis factor (TNF) and
interleukin (IL)-6 in macrophages (Gazin et al.
2004: Zhou et al. 1998).
During the Gulf War, tons of DU weapons
were ﬁred, and DU shrapnel was permanently
embedded in the bodies of many soldiers (some-
times removing shrapnel is fatal). In addition
inhalation of DU combustion particles on the
battleﬁeld is also a major source of exposure to
high concentrations of DU. It was hypothesized
that Gulf War syndrome may be explained as a
systemic shift in cytokine balance from a
T helper (Th) 1 proﬁle toward a Th2 proﬁle
because the syndrome is clinically similar to
autoimmune diseases (Rook and Zumla 1997;
Skowera et al. 2004). In this study we hypothe-
sized that DU exposure may compromise the
immune system function by inducing immune
cell apoptosis and modulating immune cell
cytokine gene expression, which may be predic-
tive of DU immunotoxicity. This hypothesis is
consistent with the ﬁndings of Li et al. (2001),
Pallardy et al. (1999), and Rodenburg et al.
(2000), which showed that cell death through
apoptosis or necrosis may cause serious adverse
effects such as immunosuppression or lead to an
altered immune response. More specifically,
because of the macrophage’s phagocytosis activ-
ity and ubiquitous presence throughout the
body, it is also important to assess the effect DU
may have on macrophage function as accessory
cells to T-lymphocyte activation/proliferation.
Cytokine gene expression profiling of DU-
exposed immune cells should contribute to the
understanding of the molecular mechanisms of
DU toxic effects on the immune system. 
To test the above hypotheses, we exposed
macrophages and primary CD4+ T cells to DU
(in the form of uranyl nitrate) and examined for
evidence of apoptosis and altered macrophage
function in promoting lymphocyte prolifera-
tion. Macrophages and T cells were also
exposed to DU at noncytotoxic concentrations,
and the effect of DU-modulated cytokine gene
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Depleted uranium (DU) is a by-product of the uranium enrichment process and shares chemical
properties with natural and enriched uranium. To investigate the toxic effects of environmental DU
exposure on the immune system, we examined the inﬂuences of DU (in the form of uranyl nitrate) on
viability and immune function as well as cytokine gene expression in murine peritoneal macrophages
and splenic CD4+ T cells. Macrophages and CD4+ T cells were exposed to various concentrations of
DU, and cell death via apoptosis and necrosis was analyzed using annexin-V/propidium iodide assay.
DU cytotoxicity in both cell types was concentration dependent, with macrophage apoptosis and
necrosis occurring within 24 hr at 100 µM DU exposure, whereas CD4+ T cells underwent cell death
at 500 µM DU exposure. Noncytotoxic concentrations for macrophages and CD4+ T cells were deter-
mined as 50 and 100 µM, respectively. Lymphoproliferation analysis indicated that macrophage
accessory cell function was altered with 200 µM DU after exposure times as short as 2 hr. Microarray
and real-time reverse-transcriptase polymerase chain reaction analyses revealed that DU alters gene
expression patterns in both cell types. The most differentially expressed genes were related to signal
transduction, such as c-jun, NF-κ Bp65, neurotrophic factors (e.g., Mdk), chemokine and chemokine
receptors (e.g., TECK/CCL25), and interleukins such as IL-10 and IL-5, indicating a possible involve-
ment of DU in cancer development, autoimmune diseases, and T helper 2 polarization of T cells. The
results are a ﬁrst step in identifying molecular targets for the toxicity of DU and the elucidation of the
molecular mechanisms for the immune modulation ability of DU. Key words: apoptosis, CD4+ T cell,
cytokine gene expression, depleted uranium, macrophage function, necrosis. Environ Health Perspect
114:85–91 (2006). doi:10.1289/ehp.8085 available via http://dx.doi.org/ [Online 17 August 2005]expression was examined. The results of these
experiments suggest a possible role for DU in
carcinogenesis and autoimmune diseases.
Materials and Methods
Chemicals. Uranyl nitrate [UO2(NO3)2·6H2O],
with a specific activity of approximately
0.2 µCi/mg, and sodium nitrate (NaNO3) 
were purchased from Mallinckrodt Specialty
Chemicals Co. (Phillipsburg, NJ) and both
were dissolved in water. Lipopolysacchride and
concanavalin A (ConA) were from Sigma (St.
Louis, MO) and were dissolved in DMSO.
[α-33P]-Deoxyadenosine 5´-triphosphate was
purchased from ICN Radiochemicals (Costa
Mesa, CA). 
Animals. BALB/c and DO11.10 T-cell
receptor (TCR)–transgenic mice were originally
obtained from The Jackson Laboratory (Bar
Harbor, ME) and bred and housed under
pathogen-free conditions in the animal care
facility at the University of Tennessee,
Knoxville, according to the animal protocol
procedures approved by the Committee on the
Care of Laboratory Animal Resources. Mice
6–8 weeks of age were used for cell preparation.
Cell preparations. Collected peritoneal
elicited macrophages were collected and pooled
from three to four Balb/c mice injected
intraperitoneally with thioglycollate (TG) broth
(3% wt/vol; 1 mL/mouse; Difco Laboratories,
Livonia, MI) 4 days before cell collection. Cells
were plated onto 25 cm2 Corning cell culture
flasks or polystyrene six-well flat-bottom
microtiter plates and were incubated at 37°C,
5% CO2/95% air, and 95% humidity for 4 hr
to allow the macrophages to adhere to the sur-
faces. The surfaces were washed twice with
warm PBS to remove all nonadherent cells, and
the macrophage layer was cultured overnight in
complete RPMI-1640 (cRPMI-1640) contain-
ing 10% low-endotoxin, heat-deactivated fetal
bovine serum (Sigma, Copenhagen, Denmark),
10–5 M 2-mercaptoethanol, L-glutamine
(20 mM), and penicillin and streptomycin
(100 U/mL each). The resulting macrophage
purity was > 95%, determined by CD11b
staining analysis. Cells were then washed twice,
stained with trypan blue exclusive dye, and
counted. The cells were exposed to uranyl
nitrate at various concentrations in 25-cm2
ﬂasks (for RNA isolation) or six-well plates (for
ﬂow cytometry analysis).
Splenic CD4+ T cells were negatively iso-
lated using the magnetic activated cell sorting
method according to the manufacturer’s proto-
cols (Miltenyi Biotec, Auburn, CA). In brief,
pooled splenic cells from three to four
DO11.10 mice were stained with a cocktail of
biotin-conjugated monoclonal antibodies
against CD8a(Ly-2) (rat IgG2a), CD11b
(Mac-1) (rat IgG2b), CD45R (B220) (rat
IgG2a), DX5 (rat IgM), and Ter-119 (rat
IgG2b). The mixture was then incubated with
Anti-Biotin MicroBeads (Miltenyi Biotec) and
the cell suspension was passed through an LS
magnetic separation column (Miltenyi Biotec).
The major cell composition of elute is CD4+
T cells (> 95%). After washing, the cell density
was adjusted to 1 × 106 cells/mL cRPMI-1640
media and the DU exposure was performed in
anti-CD3–coated 96-well plates, followed by
RNA isolation or flow cytometry analysis.
Fresh cells from new living animals were puri-
ﬁed each time the assays were repeated; three
individual experiments were performed.
Cell staining and ﬂow cytometry analysis of
cell death. For both macrophages and primary
CD4+ T cells, cell death analysis using flow
cytometry was performed in triplicate. We han-
dled and treated cells according to the protocol
provided with the Annexin-V–fluorescein
(A-V–FITC) Apoptosis Detection Kit (Sigma,
Copenhagen, Denmark). Cells (1 × 106
cells/mL) were exposed to uranyl nitrate at
0–200 µM (macrophages) or 0–500 µM (CD4+
T cells). The cells were harvested and washed
once with PBS and resuspended in 1× binding
buffer. A 500-µL aliquot of the cell suspension
was stained with 5 µL of A-V–FITC and 10 µL
of propidium iodide (PI) in a 12 × 75 mm test
tube for 10 min at room temperature, protected
from light. We then analyzed cells using the
ﬂow cytometry FACScan (BD Biosciences, San
Jose, CA) by counting 30,000 events. The data
ﬁles were saved automatically by CellQuest soft-
ware (BD Biosciences), and WinMDI (version
2.8; The Scripps Institute, Flow Cytometry
Core Facility, La Jolla, CA), was used to per-
form quadrant analysis. A two-tailed t-test was
performed to determine the signiﬁcant differ-
ence between treatment and control experi-
ments using Excel (Microsoft, Redmond, WA).
Lymphoproliferation assay. We used a
T-lymphocyte proliferation assay to estimate the
macrophage function as accessory cells. The
exposure follows the model described by
Krocova et al. (2000): elicited peritoneal
macrophages were placed into the wells of
96-well microtiter plates (Corning Inc.,
Corning, NY), allowed to adhere for 4 hr, and
then exposed to cRPMI-1640 media containing
DU (10, 50, 100, 200, 500, and 1,000 µM) or
an equal amount of medium with no DU
added. After 2 hr incubation, the cells were
washed, and then the puriﬁed CD4+ T cell sus-
pension (1 × 106 cells/mL with 5 µg/mL ConA)
was added to each well containing treated adher-
ent macrophages. Simultaneously, we set up
non–T-cell controls by replacing the T cells
with same amount of culture medium. The
plate was incubated at 37°C, 5% CO2/95% air,
and 95% humidity for 48 hr. Then, we added
10 µL of MTT [3-(4,5-dimethylthiazolyl-2)-
2,5-diphenyltetrazolium bromide] solution
(5 mg/mL) to each well, and allowed the plate
to incubate for an additional 4 hr. At the end
of the incubation, we added 100 µL of acidic
isopropanol (0.04 M HCl in absolute iso-
propanol) and mixed to dissolve the converted
dye formazan. The absorbance data were
recorded by a spectrophotometer (Bio-Tek
Instruments, Inc., Winooski, VT) at 562 nm.
Mouse cytokine cDNA microarray analysis.
The Panorama mouse cytokine gene array
(Sigma, St. Louis, MO) consisting of 514 dif-
ferent cytokine-related cDNAs printed onto
charged nylon membranes was used to analyze
gene expression proﬁle. A detailed description
and a list of genes included on the array can be
found on the Sigma-Genosys website (Sigma
2004). Brieﬂy, we exposed macrophages and
CD4+ T cells to 50 and 100 µM DU, respec-
tively, for 24 hr; after treatment, we extracted
total RNA from each sample using Trizol
reagent and treated the RNA with RNase-free
DNase I (Gibco-BRL Life Technologies Inc.,
Grand Island, NY). Using mouse cytokine gene
cDNA-labeling primers (Sigma-Genosys,
St. Louis, MO), 2 µg RNA were reverse tran-
scribed to generate a [α-33P]-dATP–labeled
cDNA probe. We removed unincorporated
nucleotides from the probe using NucTrap
probe purification columns (Stratagene,
La Jolla, CA). EDTA was added to bring the
ﬁnal concentration to 10 mM, and the probe
was heat denatured at 95°C for 5 min. Arrays
were hybridized with probes in ULTRArray
hybridization buffer (Ambion, Inc., Austin,
TX) overnight at 55°C. The arrays were then
washed extensively at 50°C under both low-
and high-stringency conditions [2× saline
sodium citrate (SSC), 0.5% SDS for low-strin-
gency wash solution, 0.5× SSC, 0.5% SDS for
high-stringency wash solution] for 2 × 30 min.
The membranes were air dried, sealed in a clear
plastic bag, and exposed to low-energy storage
phosphoimage screens (Kodak, Rochester, NY).
The images were scanned at 50-µm resolution
on a Storm 840 PhosphorImager (Molecular
Dynamics, Inc., Sunnyvale, CA). The image
ﬁles were analyzed using ArrayVision software
(version 6.0; Imaging Research, St. Catharines,
Ontario, Canada), and the numerical output
was exported in Microsoft Excel format to
ArrayStat (version 1.0; Imaging Research Inc.)
for statistical analysis. Microarray data obtained
here are available at Gene Expression Omnibus
(GEO 2005; accession no. GSE2333).
Real-time reverse-transcriptase PCR analy-
sis. Real-time reverse-transcriptase polymerase
chain reaction (RT-PCR) was used to verify
gene expression of microarray analysis. The
assay was performed in triplicate in a DNA
Engine Opticon system (MJ Research Inc.,
Waltham, MA) using SYBR Green I as the
detection format (Qiagen, Inc, Valencia, CA).
First, we converted total RNA to ﬁrst-strand
cDNA using reverse transcription, and then
performed real-time RT-PCR analysis using the
SYBR Green PCR kit (Qiagen). The PCR
primers are listed in Table 1. After PCR, we
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the PCR products using gel electrophoresis to
assess the speciﬁcity of PCR ampliﬁcation reac-
tions. For both the reference gene [glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH)]
and test gene, we constructed standard curves
and determined the slope to calculate the PCR
efﬁciency according to Pfafﬂ (2001; Pfafﬂ et al.
2002). We calculated differences in gene
expression between treatment and control using
PCR efﬁciencies and threshold cycle numbers
(Ct values), which were normalized against
GAPDH. The formulation used for calculating
the ratio of gene expression between control
and treatment groups is described by Pfaffl
(2001; Pfafﬂ et al. 2002) as 
ratio (S:C) = Etarget gene
ΔCt-target gene (control–sample)
÷ Ereference gene
ΔCt-reference gene (control–sample)
[1]
where ratio(S:C) is the expression ratio of
DU-treated sample over control; Etarget gene is
the PCR efﬁciency of target gene; Ereference gene
is the PCR efficiency of reference gene;
ΔCt-target gene (control–sample) is the differ-
ence of target gene Ct values between control
(C) and DU-treated samples (T); and ΔCt-
reference gene (control–sample) is the differ-
ence of reference gene Ct values between con-
trol and DU-treated samples.
Statistics. Data were expressed as the mean ±
SD, and a Student t-test was used to compare
the differences between treatment and control
groups, with the significance level set at
p < 0.05. For microarray data analysis, blots
were normalized to the mean values of the entire
array with background subtraction. Three sets of
data were generated from three biologic repli-
cate experiments; if there were only one valid
observation for a gene within a condition, that
datum was disregarded for analysis. The outliers
were detected by examining standardized resid-
uals automatically using ArrayStat software. A
curve-fit random error estimate method was
employed for a proportional model with offset.
The data were transformed logarithmically,
and a Z-test for two independent conditions
was performed according to Benjamini and
Hochberg (1995). Differentially expressed
genes were identiﬁed on the basis of the sig-
niﬁcance level (p < 0.05 or effective p < 0.05/
number of analyzed genes).
Results
Macrophage cell death. We determined induc-
tion of apoptosis in macrophages using 
flow cytometry analysis of cells labeled with
A-V–FITC. A-V protein can bind, by a
calcium-dependent process, to phosphatidyl-
serine (PS) presented on the surface of cells
undergoing apoptosis (Bertho et al. 2000). PS is
normally sequestered on the inner leaﬂet of the
plasma membrane. However, during apoptosis,
membrane phospholipid asymmetry is lost and
PS is exposed to the outer leaﬂet, where it can
interact with A-V. Cells that stain positively for
A-V and negatively for PI are considered cells in
an early stage of apoptosis, whereas those that
stain positively for both indicators either are in
late apoptotic stage or are undergoing necrotic
cell death.
The treatment of macrophages with DU as
uranyl nitrate resulted in apoptotic cell death.
As shown in Figure 1A, treatment with 20 and
50 µM DU for 24 hr did not cause an apparent
increase in A-V and PI staining. However, 100
and 200 µM DU treatment led to a signiﬁcant
increase of both A-V and PI staining (p < 0.05),
with the percentages of A-V binding at 12.3
and 30.5%, respectively, and the percentage of
PI positive cells at 12.4 and 49.2%, respec-
tively. The results indicated that both cell apop-
tosis and necrosis increase with an increase in
concentration. DU at 50 µM was determined
as noncytotoxic to macrophages.
Using light microscopy and atomic force
microscopy, we investigated the morphologic
changes in macrophages treated with 100 µM
DU for 24 hr (Figure 2). We treated the
macrophages with 0 or 100 µM DU for 24 hr
and fixed the cells by soaking them in 2%
formaldehyde (prepared in propanol), followed
by incubation in 0.1% Triton-X 100 for
15 min. We then air dried the cells at room
temperature in preparation for imaging by
atomic force microscopy. Alternatively, cells
after DU exposure were directly imaged by
light microscopy. When adherent macrophages
undergo necrosis or cellular disintegration,
adherent cells will disassociate and ﬂoat in the
medium. Figure 2 shows that the apoptotic
cells are still adherent to the surface and show
the rough shape of the cell membrane and no
apparent nuclear structure (Figure 2D). In the
atomic force microscopy images, the darkness
represents the height of sample surface over the
vessel surface. Note that in Figure 2C, which is
a normal cell, the thicker area (brightest) is the
nucleus of the cell, but in Figure 2D, there is
no such area, which is indicative of loss of
nuclear structure. In Figure 2D, the small
particle-like areas indicate apoptotic bodies.
CD4+ T-cell death analysis. The treatment
of CD4+ T cells with DU (as uranyl nitrate)
resulted in apoptotic as well as necrotic cell
death. As shown in Figure 1B, treatment with
1, 10, and 100 µM DU for 24 hr did not result
in signiﬁcant increase of either A-V staining or
PI staining, indicating that these treatments did
not induce cell apoptosis or necrosis. However,
there was a signiﬁcant increase of apoptotic and
necrotic cells after treatment with 500 µM DU
(p < 0.05), 64.5 and 15.3%, respectively,
whereas the apoptotic and necrotic cell percent-
ages of negative controls were 3.5 and 1.5%,
respectively. As expected, the positive controls
had a much higher percentage of necrotic cells,
whereas the percentages of necrotic and apop-
totic cells in the 1 mM NaNO3 control group
were not different from those of negative con-
trol, indicating that apoptosis and necrosis in
DU treatment were not attributable to the
NO3
– ion but were due to the uranyl ion. DU
at 100 µM was determined as noncytotoxic to
CD4+ T cells during 24-hr exposure.
Lymphoproliferation assay. Concanavalin A
(ConA) was used to activate T cells. The likely
mechanism is that ConA indirectly cross-links
the TCR and sends the activation signals.
Activation of T cells is also dependent on the
presence of non-T cells that function as acces-
sory cells, which provide additional and essen-
tial costimulatory signals for T-cell proliferation
(Coligan 1991). Exposure to DU at concentra-
tions > 200 µM significantly enhanced the
functionality of macrophages, as shown by
increased T-cell proliferation under the induc-
tion of ConA (Figure 3, solid bars). Lower
concentrations of DU < 100 µM did not
change the T-cell proliferation. However, 200,
500, and 1,000 µM DU treatment of macro-
phages signiﬁcantly (p < 0.05) enhanced T-cell
proliferation in a concentration-dependent
manner, with the optical density measurements
in MTT assay increasing from 0.56 (control) to
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Table 1. Primer sequences used in quantitative RT-PCR for differentially expressed genes 
Target Sequences Amplicon size (bp)
IL-10 F: 5´-CAT GGG TCT TGG GAA GAG AA-3´
R: 5´-CAT TCC CAG AGG AAT TGC AT-3´ 194
Mdk F: 5´-ACC GAG GCT TCT TCC TTC TC-3´
R: 5´-GGC TCC AAA TTC CTT CTT CC-3´ 230
BMP-11 F: 5´-TTC ATG GAG CTT CGA GTC CT-3´
R: 5´-AGC ATG TTG ATT GGG GAC AT-3´ 299
c-jun F: 5-TGA GAA CTT GAC TGG TTG CG-3´
R: 5´-AAA GTC CAT CGT TCT GGT CG-3´ 222
Stat-1 F: 5´-TGG TGA AAT TGC AAG AGC TG-3´
R: 5´-TGT GTG CGT ACC CAA GAT GT-3´ 119
Tlr6 F: 5´-ACA CAA TCG GTT GCA AAA CA-3´
R: 5´-GGA AAG TCA GCT TCG TCA GG-3´ 128
IL-5 F: 5´-GTC CCT ACT CAT AAA AAT CAC CA-3´
R: 5´-GAA TAG CAT TTC CAC AGT ACC C-3´ 105
GAPDHa F: 5´-TGA TGA CAT CAA GAA GGT GGT GAA G-3´
R: 5´-TCC T TG GAG GCC ATG TAG GCC AT-3´ 240
Abbreviations: F, forward primer; R, reverse primer.
aSequences are from Lee et al. (2000).0.76, 0.86, and 0.87, respectively. In addition,
1 mM NaNO3 treatment did not inﬂuence the
measurement, excluding the contribution of
nitrate ions (NO3
–) to the toxic effect on
macrophages. In this study, pretreatment of
macrophages with various concentrations of
DU for 2 hr did not cause signiﬁcant loss of
cells in 96-well plates, as shown by open bars in
Figure 3. Therefore, it is safe to preclude the
possibility that the alteration of T-cell prolifera-
tion is caused by variations in macrophage cell
numbers.
DU influence on gene expression. Gene
expression in macrophages and CD4+ T cells
under noncytotoxic DU exposure was analyzed
by cDNA microarray. The results were from
three biologic replicates. Table 2 lists 29 (6%
of all analyzed genes) genes whose expressions
were significantly (p < 0.05) changed in
macrophages upon 50 µM DU exposure. Of
these 29 genes, 24 (5%) were up-regulated,
and 5 (1%) were down-regulated. Although a
variety of gene groups are affected, the groups
with multiple affected genes include signal
transduction–related, cytokine- and IL-related,
and apoptosis-related groups. Other genes with
altered expression such as LTBP-2 and Mdk
are neurotrophic factors or involved in binding
protein, respectively.
The differentially expressed genes in 
CD4+ T cells under noncytotoxic (100 µM)
DU exposure are listed in Table 3. Although
many of the same gene groups are represented,
the specific genes, except for Mdk listed in
Tables 2 and 3 are different. Specifically,
chemokine-related genes are up-regulated 
in CD4+ T cells but not in macrophages.
Moreover, IL-5 is related to T-cell functionality.
Real-time RT-PCR analysis. We used real-
time RT-PCR analysis as a confirmative
method for the genes determined to be differ-
entially expressed by microarray analysis and
performed the analysis for selected genes in
both cell types. Table 4 shows some of the
RT-PCR results, along with the corresponding
microarray results. RT-PCR analysis showed
that under DU exposure, expression of genes
such as Mdk, c-jun, and IL-10 was enhanced in
macrophages, and Mdk and IL-5 in CD4+
T cells. The ratios of all genes except for IL-10
were in accordance with those determined by
microarray analysis. We performed the assay in
triplicate. Generally, this quantitative RT-PCR
assay conﬁrmed the microarray results.
Discussion
Uranium environmental contamination from
mining, processing, and military industries has
heightened concern of the possible environ-
mental and health effects of DU exposure. DU
can enter the body by ingestion, inhalation,
contamination of wounds, and embedded
shrapnel (McClain et al. 2001). At the cellular
level, accumulation of DU has been observed in
various macrophage cell lines (Gazin et al.
2004; Kalinich et al. 2002), and one of the ﬁrst
issues to address is whether DU induces
macrophage death and at what level this toxic
effect occurs. In this study we used ﬂow cytom-
etry analysis of A-V/PI binding to study apop-
tosis and necrosis. The results showed that
apoptosis and necrosis occurred after 24 hr with
DU (as uranyl nitrate) treatments ≥ 100 µM.
These results are similar to those observed in a
Wan et al.
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Figure 1. Cell apoptosis and necrosis under DU exposure. (A) Macrophages were treated with 0 (control), 20, 50, 100, or 200 µM DU for 24 hr. (B) CD4+ T cells were
treated with 0 (negative control), 1, 10, 100, or 500 µM DU, 1 mM NaNO3, or 1 µg/mL staurosporine (positive control) for 24 hr. Data are presented as percentage of
cells in the apoptotic or necrotic state and are the means of triplicate experiments. Error bars represent SD.
*Difference from negative control is statistically signiﬁcant (p < 0.05). 
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Figure 2. Representative bright-ﬁeld and atomic force photomicrographs of macrophages with or without
DU exposure. The cells were cultured in medium without or with 100 µM DU (as uranyl nitrate) for 24 hr
and then processed for microscopy. Bright-ﬁeld images (40× magniﬁcation) of control (A) and DU-treated
cells (B); the rough membrane structure of DU-treated cells was shown in B. Atomic force microscopy
images of single control (C) and DU-treated cells (D), with or without nucleus area, respectively. The apop-
totic body is presented in D as smaller separated bodies. The arrows in B and D indicate cells undergoing
apoptosis after 24 hr of 100 µM DU exposure. Arrow in C indicates the nucleus feature of a normal cell.previous study that used uranyl chloride and a
macrophage cell line, J774 (Kalinich et al.
2002) and were also comparable with other
reported experiments using human osteoblast
cells (Miller et al. 1998). Apoptosis and, to a
lesser extent, necrosis occurred simultaneously
after 24 hr when T cells were exposed to 
concentrations as high as 500 µM DU. Below
500 µM, apoptosis and necrosis were not
observed. CD4+ T cells are more resistant 
than macrophages, which may be because
macrophages can actively engulf DU particles
(Kalinich et al. 2002), but CD4+ T cells do not.
Compared with other heavy metals, DU is
much less toxic to CD4+ T cells than mercury,
whereas lead and vanadium have approximately
the same toxicity as DU (Shen et al. 2001).
Once the toxicity of DU to immune cells
was determined, the issue arose as to how DU
affects the function of immune cells. In the pres-
ence of ConA, in vitro T-cell activation requires
accessory cells for co-stimulatory signals (Pollard
and Landberg 2001). In the present study we
assessed the ability of DU-exposed macrophages
to function as accessory cells by measuring the
CD4+ T-cell proliferation. The results indicated
that higher concentrations (200 to ~ 1,000 µM)
of DU were able to alter macrophage function-
ality in vitro in a concentration-dependent man-
ner, which led to signiﬁcant T-cell proliferation.
This response is similar but occurs at higher
concentrations compared with other heavy 
metals such as lead, which induces lymphocyte
proliferation at a concentration range of approx-
imately 12–120 µM (Krocova et al. 2000). The
results in this study demonstrated that a short-
term, high-concentration DU exposure was able
to perturb rapidly the interaction between
macrophages and T cells, and immune function.
Previous studies on the toxic effects of
heavy metals, including uranium, indicated the
involvement of cytokine regulation in
immunomodulatory activities (Gazin et al.
2002; Krocova et al. 2000). However, these
studies focused on the expression of only a few
cytokine genes such as interleukins, NF-κB, or
TNF-α. Global gene expression analysis in kid-
ney tissue after DU exposure suggested that
genes involved in multiple biologic functions,
including signal transduction, may be altered
by uranium exposure (Taulan et al. 2004). We
further asked what effects DU might have on
the immune system if the exposure scenario
Effects of depleted uranium on cells and gene expression
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Figure 3. Effect of DU on the accessory cell function of peritoneal adherent macrophages. The effect of DU
on lymphocyte (CD4+ T cell) proliferation was determined by MTT assay, which indirectly reflects the
accessory cell function of macrophages in promoting lymphocyte proliferation. Results are expressed in
optical density values read at 562 nm wavelength as mean and SD of triplicate analyses. 
*Difference from control is statistically signiﬁcant (p < 0.05). 
Table 2. Differentially regulated genes in DU-exposed peritoneal adherent macrophages as determined by array analysis.
Accession
Gene abbreviationa Gene symbola no.b Gene description Gene group Z-Testc Ratiod 95% CIe
Up-regulated gene expression
NF-kB p65 Rela NM_009045 avian reticuloendotheliosis viral (v-rel) oncogene homolog A Signal transduction 5.8 × 10–8 3.9 6.3–2.4
LTBP-2 Ltbp2 AF004874 latent TGF-beta binding protein-2 Binding protein 1.8 × 10–6 3.2 5.3–2.0
WNT-8b Wnt8b NM_011720 wingless related MMTV integration site 8b Developmental factors 9.3 × 10–6 3.2 5.4–1.9
Mdk Mdk NM_010784 midkine Neurotrophic group 1.5 × 10–5 3.1 5.2–1.9
c-jun Jun NM_010591 Jun oncogene Signal transduction 7.1 × 10–5 3.2 5.8–1.8
Map3k14 Nik—pending NM_016896 Nfkb inducing kinase Apoptosis related 1.5 × 10–3 2.4 4.0–1.4
BDNF Bdnf NM_007540 brain derived neurotrophic factor Neurotrophic group 2.4 × 10–3 1.7 2.5–1.2
SOCS-1 Cish1 NM_009896 cytokine inducible SH2-containing protein 1 Signal transduction 2.8 × 10–3 2.4 4.2–1.4
c-myc Myc NM_010849 myelocytomatosis oncogene Signal transduction 7.2 × 10–3 2.2 3.8–1.2
NSG1/p21 Nsg1 NM_010942 neuron speciﬁc gene family member 1 Signal transduction 7.8 × 10–3 2.0 3.3–1.2
IL-10 Il10 NM_010548 interleukin 10 Interleukin 8.2 × 10–3 1.7 2.5–1.2
Stat 1 Stat1 NM_009283 signal transducer and activator of transcription 1 Signal transduction 9.2 × 10–3 2.0 3.4–1.2
IL-12 Rb1 Il12rb1 NM_008353 interleukin 12 receptor, beta 1 Interleukin receptor 1.1 × 10–2 1.6 2.4–1.1
CIS3 Cish3 NM_007707 cytokine inducible SH2-containing protein 3 Signal transduction 1.1 × 10–2 1.8 2.8–1.1
BMP-9 Bmp9 AF188286 bone morphogenetic protein 9 TGF-beta family 1.4 × 10–2 1.8 2.7–1.1
SMAD7 Madh7 NM_008543 MAD homolog 7 (Drosophila) Signal transduction 1.9 × 10–2 1.6 2.5–1.1
Tlr2 Tlr2 AF185284 toll-like receptor 2 Cell surface protein 1.9 × 10–2 1.8 2.8–1.1
CT-1 Ctf1 NM_007795 cardiotrophin 1 Cytokine and receptors 1.9 × 10–2 1.9 3.4–1.1
EphA3 Epha3 M68513 mouse eph-related receptor tyrosine kinase (Mek4) Eph family 2.1 × 10–2 1.6 2.3–1.1
MMP-13 Mmp13 NM_008607 matrix metalloproteinase 13 Protease or related factor 2.2 × 10–2 1.9 3.3–1.1
BMP-11 Gdf11 AF092734 growth/differentiation factor 11 TGF-beta family 3.2 × 10–2 1.8 3.1–1.0
GDNF Gdnf D49921 glial cell line-derived neurotrophic factor (GDNF) Neurotrophic group 3.5 × 10–2 1.6 2.4–1.0
Itgb7 Itgb7 M95632 integrin beta-7 subunit Intergrin 2.9 × 10–2 1.7 2.9–1.0
MMP-8 Mmp8 NM_008611 matrix metalloproteinase 8 Protease or related factor 4.9 × 10–2 1.6 2.5–1.0
Down-regulated gene expression
Tlr6 Tlr6 NM_011604 toll-like receptor 6 Cell surface protein 2.7 × 10–2 0.6 0.9–0.4
Cox-2 Ptgs2 NM_011198 prostaglandin-endoperoxide synthase 2 Apoptosis related 2.3 × 10–2 0.6 0.9–0.4
VCAM-1 Vcam1 NM_011693 vascular cell adhesion molecule 1 Adhesion molecule 1.2 × 10–2 0.5 0.9–0.3
FLIPL Cash NM_009805 caspase homolog Apoptosis related 1.1 × 10–2 0.6 0.9–0.4
SARP-1 Sdf5 NM_009144 stromal cell derived factor 5 Apoptosis related 7.3 × 10–4 0.6 0.8–0.4 
Results are from three individual experiments. 
aFrom Sigma-Genosys (http://www.sigmaaldrich.com/catalog/search/ProductDetail/GENOSYS/G2041). bFrom GenBank (http://www.ncbi.nlm.nih.gov/Genbank/). cp-Values in the two-
tailed Z-tests for the comparison between control and DU treatments. dThe ratio expression values for the average expression values of each gene between DU and control, that is,
ratio = intensity value from DU-treated cells divided by that from control cells. eConﬁdence intervals (CIs) determined for ratios, p < 0.05.were nonlethal and long term and how it
might relate to cytokine gene expression.
In this present study we used a mouse
cytokine gene array, and as expected, genes
related to signal transduction pathways were
significantly modulated by DU exposure
(Tables 2, 3). In DU-exposed macrophages the
most highly expressed gene was NF-κB p65
(Table 2). Miller et al. (2004) demonstrated
that DU (5–50 µg/mL or 18.5–185 µM) had
profound inﬂuences on multiple signaling path-
ways in HepG2 cells; interestingly, the genes
they identiﬁed also related to the NF-κB path-
way, as indicated in our research. The impor-
tant role of NF-κB in uranium toxic effects has
been reported previously by Gazin et al. (2002).
Our results provide direct evidence showing
that DU is able to activate NF-κB by increasing
the expression of the p65 subunit. The NF-κB
family of transcription factors not only are key
regulators of genes involved in immune and
inﬂammatory reactions (Li et al. 2001; Tak and
Firestein 2001) but also are involved in many
aspects of cell growth, differentiation, and pro-
liferation via the induction of certain growth
and transcription factors (e.g., c-myc, ras, p53).
The co-induction of NF-κB, MMP-13, and
c-myc indicated in our microarray results is con-
sistent with previous work by Tak and Firestein
(2001).
NF-κB can mediate both inflammatory 
and antiinﬂammatory responses by regulating 
genes encoding either proinflammatory or
antiinflammatory activities (e.g., IL-10)
(Baldwin 2001; Bierhaus and Nawroth 2003;
Xu and Shu 2002). In our microarray analysis,
the latter was indicated by the up-regulation of
IL-10 gene in macrophages upon DU exposure
(Table 2). Activation of NF-κB requires degra-
dation of I-κB (nucear factor of kappa light
chain gene enhancer in B-cells inhibitor, β)
with the help of I-κB kinases, the activity of
which depends on binding with NF-κB–
inducing kinase (NIK) (Chen et al. 2001;
Wooten 1999). The activation of NIK as
shown in this study (Table 2) supports the
conclusion that the NF-κB signaling pathway
was adopted by macrophages under the DU
exposure. DU may induce NIK activity lead-
ing to the up-regulation of NF-κB (by increas-
ing the p65 subunit level), which further
activates expression of a variety of cytokine
genes, such as c-myc and MMP-13, as indicated
in our array data. This hypothesis is supported
by the study of Miller et al. (1998) that
demonstrated DU-induced tumorigenic activ-
ity in osteoblast cells.
It is interesting to note that the expression
of the neurotrophic factor Mdk was highly
induced in both primary macrophages and
CD4+ T cells (Tables 2, 3) after DU exposure.
Mdk gene expression is restricted to only a few
types of cells such as kidney and epithelial cells
(Garver et al. 1993; Hu et al. 2002); it is very
unusual that this gene was regulated by DU in
immune cells. To our knowledge [main refer-
ences were Tully et al. (2000) and Yamada and
Koizumi (2002)], the up-regulation of Mdk by
heavy metal exposure has not been previously
reported, which may indicate a common
mechanism of DU immunotoxicity to both
macrophages and T cells and may provide a
biologic marker for DU exposure. Because
Mdk levels often increase in the early stage of
cancer progression, it has been suggested as a
tumor marker (Muramatsu 2002). High
induction of Mdk expression in this study pre-
sents further evidence for the possible involve-
ment of DU in carcinogenesis, as reported by
Miller et al. (1998).
A DU-induced Th1–Th2 shift has been
long postulated to play a role in the develop-
ment of Gulf War syndrome (Rook and Zumla
1997; Skowera et al. 2004). The complex bal-
ance between Th1 and Th2 cells can be dis-
turbed by a variety of factors, including heavy
metals; a shift to a Th2 phenotype has been
correlated with the development of allergic
responses and some autoimmune diseases
(Harber et al. 2000; Mosmann and Sad 1996).
As part of our efforts, cytokine gene expression
was studied in CD4 cells to investigate the
DU-induced Th2 shift hypothesis.
Our array data showed an approximately
2-fold induction of IL-5 expression in CD4+
T cells and 1.7-fold induction of IL-10 in
macrophages upon DU exposure (Tables 2, 3).
We postulate that the reason changes in TNF
and IL-6 were not detected, as reported by
Krocova et al. (2000), is because of differences
in exposure conditions and cell type (we used
mouse primary peritoneal macrophages vs. rat
alveolar macrophages and lung fibroblasts).
However, the conclusions were similar because
IL-10 and IL-5 were found to be up-regulated,
and both genes are of the Th2 type. IL-5 is a
signature cytokine of Th2 cells, which also pro-
duce cytokines such as IL-4 and IL-10 (Cousins
et al. 2002; Mazzarella et al. 2000). IL-10 can
also create a microenvironment to facilitate
Th2 cell development (Malefyt et al. 1991;
Mosmann and Sad 1996). Therefore, up-regu-
lation of IL-5 and IL-10 expression in our study
indicates a Th2 differentiation tendency after
DU exposure. This is direct evidence, at the
transcriptional level, for a DU-induced Th2
shift. Th2 domination of T-helper cell popula-
tion differentiation is often found in association
Wan et al.
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Table 4. Comparison of the gene expression ratios
in macrophages determined by microarray and
quantitative RT-PCR analysis.
Gene abbreviation Array ratios RT-PCR ratioc
Mdka 3.1 3.2
c-juna 3.2 1.9
BMP-11a 1.8 1.6
Stat-1a 2.0 2.2
IL-10a 1.7 6.9
Tlr6a 0.6 0.6
Mdkb 3.0 1.9
IL-5b 1.9 3.2
aThe gene was differentially expressed in macrophages.
bThe gene was differentially expressed in CD4+ T cells.
cResults from triplicate s (n = 3).
Table 3. Differentially regulated genes in DU-exposed CD4+ T cells as determined by array analysis.
Gene abbreviationa Gene symbola Accession no.b Gene description Gene group Z-Testc Ratiod 95% CIe
Up-regulated gene expression
TECK/CCL25 Scya25 NM_009138 small inducible cytokine A25 Chemokine 1.5 × 10–14 4.2 6.2–2.9
Mdk Mdk NM_010784 midkine Neurotrophic group 2.9 × 10–7 3.0 4.7–1.9
IL-5 Il5 NM_010558 interleukin 5 Interleukin 9.5 × 10–4 1.9 2.9–1.3
VEGF-A Vegf NM_009505 vascular endothelial growth factor Angiogenic factor 2.5 × 10–5 1.8 2.2–1.4
Down-regulated gene expression
EphA3 Epha3 M68513 eph-related receptor tyrosine kinase (Mek4) Eph family 4.0 × 10–8 0.5 0.6–0.4
CCR-4 Cmkbr4 NM_009916 chemokine (C-C) receptor 4 Chemokine receptor 1.8 × 10–5 0.6 0.8–0.5
LIF Lif NM_008501 leukemia inhibitory factor Cytokine and receptors 3.0 × 10–5 0.6 0.8–0.4
GDF-7 Gdf7 U08339 BALB/c putative growth factor GDF7 (Gdf7) gene TGF-beta superfamily 2.4 × 10–4 0.5 0.7–0.3
EBF Ebf NM_007897 early B-cell factor Signal transduction 3.7 × 10–4 0.5 0.7–0.4
CD27/TNFRSF7 Tnfrsf7 L24495 CD27 antigen TNF superfamily 6.4 × 10–4 0.6 0.8–0.4
SLIT-3 Slit3 AF088902 SLIT1 protein Developmental factor 9.2 × 10–4 0.7 0.8–0.5
CX3CL1 Scyd1 NM_009142 small inducible cytokine subfamily D, 1 Chemokine 1.2 × 10–3 0.4 0.7–0.2
SMAD1 Madh1 NM_008539 MAD homolog 1 (Drosophila) Signal transduction 1.3 × 10–3 0.6 0.8–0.5
A1 Bcl2a1a L16462 hemopoietic-speciﬁc early response protein Apoptosis related 1.5 × 10–3 0.6 0.8–0.4
Results are from three individual experiments. 
aFrom Sigma-Genosys (http://www.sigmaaldrich.com/catalog/search/ProductDetail/GENOSYS/G2041). bFrom GenBank (http://www.ncbi.nlm.nih.gov/Genbank/). cp-Values in the two-
tailed Z-tests for the comparison between control and DU treatments. dThe ratio expression values for the average expression values of each gene between DU and control, that is,
ratio = intensity value from DU-treated cells divided by that from control cells. e95% Conﬁdence intervals (CIs) determined for ratios, p < 0.05.with strong antibody (e.g., autoimmune dis-
eases) and allergic responses (Harber et al.
2000; Mosmann and Sad 1996). Interestingly,
elevated blood IL-10 concentrations have been
detected in symptomatic Gulf War veterans
who were potentially exposed to DU under bat-
tleﬁeld conditions (Skowera et al. 2004; Zhang
et al. 1999). The data in our study show that
DU may contribute to an increase in IL-10 lev-
els through its action on macrophages.
Additionally, the induction of IL-5 expression
in CD4+ T cells, and possibly IL-10 in
macrophages suggests an important role for
DU in promoting Th2 shifting.
Conclusions
In summary we have demonstrated DU-
induced apoptosis and necrosis in both peri-
toneal macrophages and splenic CD4+ T cells
in a cell-speciﬁc and concentration-dependent
manner. Short-term DU exposure (> 200 µM)
to macrophages interferes with the interplay
between macrophages and CD4+ T cells, result-
ing in an enhanced T-cell proliferation
response. At lower (noncytotoxic) concentra-
tions, DU has the potential to influence
immune function by modulating cytokine gene
expression mainly involved in signal transduc-
tions, interleukin production, chemokine and
chemokine receptors, and neurotrophic factors.
Array analyses have successfully identified 
differentially regulated genes implicating DU 
in carcinogenesis and the development of 
autoimmune diseases. The up-regulation of 
IL-5 and IL-10 genes in CD4+ T cells and
macrophages, respectively, strongly suggests a
DU-induced Th2 shift during naive T-cell dif-
ferentiation. Considering the substantial
sequence homology between the mouse and
human genome and the conserved expression
patterns of orthologs reﬂecting common physi-
ologic functions in these two organisms (Su
et al. 2002), the alteration in immune functions
and cytokine gene expression in murine
immune cells demonstrated in this study iden-
tify putative molecular targets for the toxic
actions of DU and suggest molecular mecha-
nisms for the development of DU-related 
diseases in humans.
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